Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
University of New Orleans
InstitutionResearch output, impact & collaborations
University of New Orleans is a research organisation in New Orleans, US. OpenAlex records 21,651 works and 1,165,144 citations for it. 3,873 researchers list it as their most recent affiliation.
21,651
Works
1,165,144
Citations
3,873
Researchers
84.8
Avg h-index
How has University of New Orleans's publication output changed over time?
ScholarIQpublication output · 2003–2022
Output grew100% over the shown period — from 1 works in 2003 to 2 in 2022.
1
1
2
1
1
2
1
2
20032004201520182019202020212022
Who are the most-cited researchers behind University of New Orleans?
ScholarIQtop researchers by citations
What are the most-cited papers on University of New Orleans?
ScholarIQmost cited works
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Guangping Gao, Luk H. Vandenberghe, Mauricio R. Alvira, You Lü, Roberto Calcedo, Xiangyang Zhou, James M. Wilson
S96615428. 20041,067 CitationsOPEN ACCESS
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
You Lü, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang, Haige Shen, Ruizhan Tong, Wenbo Wang, Li Li, Jin Sook Song, Jing Li, Xiaoxing Su, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Bingwen Zou, Yan Zhang, Yanying Li, Lin Zhou, Yongmei Liu, Min Yu, Yuqi Wang, Xuanwei Zhang, Limei Yin, Xuefeng Xia, Yong Zeng, Qiao Zhou, Binwu Ying, Chong Chen, Yuquan Wei, Weimin Li, Tony Mok
Nature Medicine. 2020544 Citations
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
Jean‐Charles Soria, Yi‐Long Wu, Kazuhiko Nakagawa, Sang-We Kim, Jin-Ji Yang, Myung‐Ju Ahn, Jie Wang, James Chih‐Hsin Yang, You Lü, Shinji Atagi, Santiago Ponce, Ki Hyeong Lee, Yunpeng Liu, Kiyotaka Yoh, Jianying Zhou, Xiaojin Shi, Alan Webster, Haiyi Jiang, Tony Mok
The Lancet Oncology. 2015412 Citations
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
Yunpeng Yang, Zhehai Wang, Jian Fang, Qitao Yu, Baohui Han, Shundong Cang, Gongyan Chen, Xiaodong Mei, Zhixiong Yang, Rui Ma, Minghong Bi, Xiubao Ren, Jianying Zhou, Baolan Li, Yong Song, Jifeng Feng, Juan Li, Zhiyong He, Rui Zhou, Weimin Li, You Lü, Yingyi Wang, Lijun Wang, Nong Yang, Yan Zhang, Zhuang Yu, Yanqiu Zhao, Conghua Xie, Ying Cheng, Hui Zhou, Shuyan Wang, Donglei Zhu, Wen Zhang, Li Zhang
Journal of Thoracic Oncology. 2020399 CitationsOPEN ACCESS
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Xiaoqing Liu, Yunzhong Zhu, Shun Lü, Jifeng Feng, Jianxing He, Baohui Han, Jie Wang, Guoliang Jiang, Chunhong Hu, Hao Zhang, Gang Cheng, Xiangqun Song, You Lü, Hongming Pan, Wenjuan Zheng, Anny-Yue Yin
Journal of Clinical Oncology. 2015391 CitationsOPEN ACCESS
How much of the research on University of New Orleans is open access?
ScholarIQopen access share
55%OPEN ACCESS
Gold
0%
Green
9%
Hybrid
36%
Bronze
9%
Closed
45%